Sign inGet started

CANNON MICHAEL D

Insider CIK 1203602 · ATNX Director · MBRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MBRX Moleculin Biotech, Inc. A Award deriv2025-11-122025-11-14150,000— $0165,336SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2024-11-042024-11-0610,000— $015,336SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2023-05-252023-05-2615,000— $080,001SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2022-06-202022-06-2215,000— $065,001SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2022-06-202022-06-2223,333— $050,001SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2021-06-072021-06-0910,000— $026,668SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2020-06-152020-06-1715,000— $0100,000SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2019-07-112019-07-1535,000— $0120,000SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2019-05-222019-05-2415,000— $085,000SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2018-06-062018-06-0835,000— $070,000SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2017-07-242017-07-2615,000— $035,000SEC↗
ATNX Athenex, Inc. A Award deriv2017-06-192017-06-2118,000— $018,000SEC↗
ATNX Athenex, Inc. A Award deriv2017-06-142018-04-2718,000— $018,000SEC↗
ATNX Athenex, Inc. A Award deriv2017-06-132018-08-2118,000— $018,000SEC↗
MBRX Moleculin Biotech, Inc. A Award deriv2016-09-232016-09-2720,000— $020,000SEC↗